1. Home
  2. WLFC vs DAWN Comparison

WLFC vs DAWN Comparison

Compare WLFC & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLFC
  • DAWN
  • Stock Information
  • Founded
  • WLFC 1985
  • DAWN 2018
  • Country
  • WLFC United States
  • DAWN United States
  • Employees
  • WLFC N/A
  • DAWN N/A
  • Industry
  • WLFC Industrial Specialties
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • WLFC Consumer Discretionary
  • DAWN Health Care
  • Exchange
  • WLFC Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • WLFC 1.3B
  • DAWN 1.3B
  • IPO Year
  • WLFC 1996
  • DAWN 2021
  • Fundamental
  • Price
  • WLFC $198.01
  • DAWN $12.54
  • Analyst Decision
  • WLFC
  • DAWN Strong Buy
  • Analyst Count
  • WLFC 0
  • DAWN 7
  • Target Price
  • WLFC N/A
  • DAWN $36.33
  • AVG Volume (30 Days)
  • WLFC 40.4K
  • DAWN 1.2M
  • Earning Date
  • WLFC 03-12-2025
  • DAWN 02-24-2025
  • Dividend Yield
  • WLFC 0.63%
  • DAWN N/A
  • EPS Growth
  • WLFC 113.10
  • DAWN N/A
  • EPS
  • WLFC 14.15
  • DAWN N/A
  • Revenue
  • WLFC $520,429,000.00
  • DAWN $101,953,000.00
  • Revenue This Year
  • WLFC N/A
  • DAWN N/A
  • Revenue Next Year
  • WLFC N/A
  • DAWN $35.22
  • P/E Ratio
  • WLFC $13.99
  • DAWN N/A
  • Revenue Growth
  • WLFC 35.45
  • DAWN N/A
  • 52 Week Low
  • WLFC $46.20
  • DAWN $11.13
  • 52 Week High
  • WLFC $235.43
  • DAWN $18.07
  • Technical
  • Relative Strength Index (RSI)
  • WLFC 43.47
  • DAWN 49.68
  • Support Level
  • WLFC $192.03
  • DAWN $11.13
  • Resistance Level
  • WLFC $229.67
  • DAWN $13.30
  • Average True Range (ATR)
  • WLFC 12.81
  • DAWN 0.51
  • MACD
  • WLFC -1.69
  • DAWN 0.05
  • Stochastic Oscillator
  • WLFC 15.89
  • DAWN 64.98

About WLFC Willis Lease Finance Corporation

Willis Lease Finance Corp with its subsidiaries is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments namely Leasing and Related Operations which involves acquiring and leasing, pursuant to operating leases, commercial aircraft, aircraft engines and other aircraft equipment and the selective purchase and resale of commercial aircraft engines and other aircraft equipment and other related businesses and Spare Parts Sales segment involves the purchase and resale of after-market engine parts, whole engines, engine modules and portable aircraft components. The company generates the majority of its revenue from leasing and related operations.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

Share on Social Networks: